Literature DB >> 22122689

Development and psychometric evaluation of a Japanese scale to assess depression severity: Himorogi Self-rating Depression Scale.

Chizu Mimura1, Mariko Murashige, Toshihiko Oda, Yoshinori Watanabe.   

Abstract

OBJECTIVE: The 17-item Hamilton Rating Scale for Depression (HAMD-17) is the most widely used instrument to assess depression severity, but it has a number of limitations in clinical use. There is no depression scale designed for Japanese culture that has been shown to be valid. This study aimed to develop a Japanese depression scale, the Himorogi Self-rating Depression Scale (HSDS), and to assess psychometric properties of it.
METHODS: Data were collected using the HSDS and the HAMD-17 from 204 outpatients of psychiatric clinics. Follow-up data were collected three times with an interval of at least 4 weeks, and reliability and validity were longitudinally observed.
RESULTS: Principal component analysis found a uni-factorial nature for both scales. The HSDS indicated stronger factor coefficients and a larger variance than the HAMD-17. ROC analysis showed high ability to distinguish between the presence and absence or remission of depression. High convergent validity and reliability coefficients were consistently indicated.
CONCLUSIONS: Although the convenience sample restricts generalisability of the findings and only a single instrument was used as a standard for comparison, reliability and validity for the HSDS was supported. The HSDS is suggested as a substitute for the HAMD-17 in clinical use.

Entities:  

Mesh:

Year:  2010        PMID: 22122689     DOI: 10.3109/13651501.2010.509801

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  4 in total

1.  Long-term efficacy and safety of lamotrigine for all types of bipolar disorder.

Authors:  Yoshinori Watanabe; Seiji Hongo
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-20       Impact factor: 2.570

2.  Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study.

Authors:  Tempei Otsubo; Yoshinori Watanabe; Seiji Hongo; Mikichika Inoue; Kimiko Akimoto; Ken Murakami; Ryutaro Takahashi; Toshiaki Kikuchi
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-06       Impact factor: 2.570

3.  Self-report depression screening measures for older Hispanic/Latin American adults: A PRISMA systematic review.

Authors:  Andrea Ochoa Lopez; Michelle N Martinez; Joshua M Garcia; Mark E Kunik; Luis D Medina
Journal:  J Affect Disord       Date:  2021-06-25       Impact factor: 4.839

4.  Acupuncture for the Treatment of Depression and Physical Symptoms in Chronic Bipolar Disorder: A Case Report.

Authors:  Yuto Matsuura; Yoshinori Watanabe; Hiroshi Taniguchi; Yoshihisa Koga; Fumiko Yasuno; Tomomi Sakai
Journal:  Clin Med Insights Case Rep       Date:  2020-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.